• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者肺动脉高压的评估:非侵入性检查与右心导管检查结果的比较。

Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.

作者信息

Hsu Vivien M, Moreyra Abel E, Wilson Alan C, Shinnar Meir, Shindler Daniel M, Wilson Julianne E, Desai Ami, Seibold James R

机构信息

University of Medicine and Dentistry of New Jersey Scleroderma Program, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

出版信息

J Rheumatol. 2008 Mar;35(3):458-65. Epub 2008 Jan 15.

PMID:18203320
Abstract

OBJECTIVE

Pulmonary hypertension (PH) is an ominous complication in patients with scleroderma (systemic sclerosis, SSc). We compared noninvasive assessment of PH with pulmonary artery (PA) pressures obtained by right-heart catheterization (RHC).

METHODS

Forty-nine patients with SSc were evaluated for suspected PH based on clinical findings, progressive dyspnea, and pulmonary function tests (PFT). PH was defined as mean PA pressure > or = 25 mm Hg, or > or = 30 mm Hg after exercise, with normal pulmonary capillary wedge pressure (PCW). Doppler echocardiography (echo) and cardiac magnetic resonance imaging (MRI) were performed within 4 hours of RHC, and the predictive accuracy of the tests was compared.

RESULTS

RHC identified 24/49 (49%) patients with PH. The noninvasive cutpoints were: estimated right ventricular systolic pressure > 47 mm Hg by echo; diameter of the main PA > 28 mm by MRI; and the ratio of forced vital capacity to diffusion capacity (%FVC/%DLCO) > 2.0 by PFT. Echo classified 38 subjects correctly (14/24 with and 24/25 without PH; sensitivity 58%, specificity 96%). The area under receiver-operating characteristic curve (AUC) was 0.84 for echo. MRI measurement of PA diameter had a sensitivity of 68% and specificity 71% (AUC 0.78). PFT evaluation had a sensitivity of 71% and specificity of 72% (AUC 0.76).

CONCLUSION

In evaluation of SSc with suspected PH, echo appeared to be the most useful among the noninvasive tests, mainly due to the high specificity, high positive predictive value, and highest AUC. However, due to the low sensitivity of noninvasive testing, RHC should remain the gold standard.

摘要

目的

肺动脉高压(PH)是硬皮病(系统性硬化症,SSc)患者的一种严重并发症。我们比较了PH的非侵入性评估与通过右心导管检查(RHC)获得的肺动脉(PA)压力。

方法

根据临床表现、进行性呼吸困难和肺功能测试(PFT),对49例SSc患者进行疑似PH评估。PH定义为平均PA压力≥25 mmHg,或运动后≥30 mmHg,且肺毛细血管楔压(PCW)正常。在RHC后4小时内进行多普勒超声心动图(echo)和心脏磁共振成像(MRI),并比较这些检查的预测准确性。

结果

RHC确定49例患者中有24例(49%)患有PH。非侵入性切点为:echo显示估计右心室收缩压>47 mmHg;MRI显示主PA直径>28 mm;PFT显示用力肺活量与弥散能力之比(%FVC/%DLCO)>2.0。echo正确分类了38名受试者(24例中有14例患有PH,25例中无PH的有24例;敏感性58%,特异性96%)。echo的受试者操作特征曲线下面积(AUC)为0.84。PA直径的MRI测量敏感性为68%,特异性为71%(AUC 0.78)。PFT评估敏感性为71%,特异性为72%(AUC 0.76)。

结论

在评估疑似PH的SSc时,echo似乎是最有用的非侵入性检查,主要是因为其高特异性、高阳性预测值和最高的AUC。然而,由于非侵入性检查的敏感性较低,RHC仍应作为金标准。

相似文献

1
Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.系统性硬化症患者肺动脉高压的评估:非侵入性检查与右心导管检查结果的比较。
J Rheumatol. 2008 Mar;35(3):458-65. Epub 2008 Jan 15.
2
Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.利用肺功能测试提高系统性硬化症中肺动脉高压的检测率。
Arthritis Rheum. 2011 Nov;63(11):3531-9. doi: 10.1002/art.30535.
3
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.在法国一项全国性多中心纵向研究中,系统性硬化症相关肺动脉高压的三年发病率。
Arthritis Rheum. 2009 Jun;60(6):1831-9. doi: 10.1002/art.24525.
4
Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.系统性硬化症中的肺动脉高压:早期检测与治疗的必要性
Intern Med J. 2007 Jul;37(7):485-94. doi: 10.1111/j.1445-5994.2007.01370.x.
5
Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.超声心动图和肺功能测试的联合应用可预测系统性硬化症患者 5 年内肺动脉高压无并发症。
Int J Rheum Dis. 2023 Mar;26(3):493-500. doi: 10.1111/1756-185X.14576. Epub 2023 Feb 3.
6
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.硬皮病肺动脉高压评估与转归识别(PHAROS)队列研究中高危系统性硬化症人群肺动脉高压的发生情况
Semin Arthritis Rheum. 2014 Aug;44(1):55-62. doi: 10.1016/j.semarthrit.2014.03.002. Epub 2014 Mar 5.
7
Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.心室质量指数与肺动脉压力相关,并可预测疑似系统性硬化症相关肺动脉高压患者的生存率。
Rheumatology (Oxford). 2009 Sep;48(9):1137-42. doi: 10.1093/rheumatology/kep187. Epub 2009 Jul 14.
8
A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension.基于非侵入性磁共振成像的肺动脉高压肺动脉压估算方法比较
J Magn Reson Imaging. 2005 Jul;22(1):67-72. doi: 10.1002/jmri.20338.
9
Prevalence of exercise pulmonary arterial hypertension in scleroderma.硬皮病中运动性肺动脉高压的患病率
J Rheumatol. 2008 Sep;35(9):1812-6. Epub 2008 Jul 15.
10
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.硬皮病中间质性肺疾病和肺动脉高压患者6分钟步行试验的局限性
J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.

引用本文的文献

1
Pulmonary artery wall thickness and systemic sclerosis: influence of inflammation on vascular changes.肺动脉壁厚度与系统性硬化症:炎症对血管变化的影响
Turk J Med Sci. 2025 Mar 24;55(3):644-651. doi: 10.55730/1300-0144.6011. eCollection 2025.
2
Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual.早期系统性硬化症中的免疫抑制药物与损害累积的预防
Arthritis Care Res (Hoboken). 2025 May;77(5):640-648. doi: 10.1002/acr.25467. Epub 2025 Feb 2.
3
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in Patients with Lupus Nephritis.
狼疮性肾炎患者肺动脉高压的患病率、预测因素和结局。
Medicina (Kaunas). 2024 Jun 17;60(6):988. doi: 10.3390/medicina60060988.
4
Exploratory clinical subgroup clustering in systemic sclerosis: Results from the Indian Progressive Systemic Sclerosis Registry.系统性硬化症的探索性临床亚组聚类:来自印度进行性系统性硬化症登记处的结果。
J Scleroderma Relat Disord. 2024 Feb;9(1):29-37. doi: 10.1177/23971983231215470. Epub 2023 Dec 14.
5
Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.土耳其早期系统性硬化症患者的扩展自身抗体谱:共表达及其对临床表型的影响。
Immun Inflamm Dis. 2023 Dec;11(12):e1089. doi: 10.1002/iid3.1089.
6
Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension.系统性硬化症患者中无明显肺动脉高压的肺动脉僵硬度评估。
Int J Cardiovasc Imaging. 2022 Oct;38(10):2191-2197. doi: 10.1007/s10554-022-02625-9. Epub 2022 May 28.
7
Occupation as a gendered-role and outcome in systemic sclerosis.职业作为一种性别角色与系统性硬化症的结局
J Scleroderma Relat Disord. 2023 Jun;8(2):131-136. doi: 10.1177/23971983221143599. Epub 2022 Dec 19.
8
Clinical phenotype in scleroderma patients based on autoantibodies.基于自身抗体的硬皮病患者临床表型
Rheumatol Adv Pract. 2023 Mar 24;7(Suppl 1):i26-i33. doi: 10.1093/rap/rkad010. eCollection 2023 Apr.
9
Artificial Intelligence-Enabled Electrocardiogram Improves the Diagnosis and Prediction of Mortality in Patients With Pulmonary Hypertension.人工智能辅助心电图可改善肺动脉高压患者的死亡率诊断和预测。
JACC Asia. 2022 May 17;2(3):258-270. doi: 10.1016/j.jacasi.2022.02.008. eCollection 2022 Jun.
10
Computational models of ventricular mechanics and adaptation in response to right-ventricular pressure overload.心室力学及对右心室压力过载反应的适应性计算模型。
Front Physiol. 2022 Aug 24;13:948936. doi: 10.3389/fphys.2022.948936. eCollection 2022.